← Leaderboards
Roland E Baron
Massachusetts General Hospital
$29,888,429
Attributed
$32,607,415
Total exposure
15
Grants
13
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.3M · FY2005–25$2.5M$1.9M$1.3M$625K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$32,607,415 · 15
By mechanism
R01$29,899,742 · 12
P50$1,285,714 · 1
R37$997,720 · 1
R21$424,239 · 1
Top collaborators
- Clifford J Rosen9 shared
- Mary L Bouxsein2 shared
Most similar at Massachusetts General Hospital
Same institution · by research overlap
- Benjamin Z Leder$7,400,681
- Sekar Kathiresan$50,580,753
- Peter Christmas$2,183,578
- Marytheresa Ifediba$58,450
- Basil A Ince$43,606
Others in their field
Top investigators on “Osteoporosis”
- Kathryn Hirst · Caritas St. Elizabeth'S Medical Center$57,671,528
- Steven R Cummings · University Of California San Francisco$56,375,786
- Richard A Gibbs · Baylor College Of Medicine$49,965,365
- Peter J. Snyder · University Of Pennsylvania$36,531,878
- Douglas P. Kiel · Hebrew Rehabilitation Center For Aged$32,610,184
- Eric S. Orwoll · Oregon Health And Science University$28,146,073
Research focus
OsteoporosisRegulationSignal TransductionProteinsBoneCellsMolecularBone ResorptionResponsePathway InteractionsAffectOsteogenesisIn VivoBaseOsteoclastsIn VitroLinkBone MassPlayInvestigationMediatingSkeletonMutantPhenotype
Grant awards (78)
The role of the osteocyte in responses to osteoporosis anabolic treatment in humans and mice$433,997
P50 · FY2025 · AR · contact PI
Mechanism of action of PTH: New signaling components that regulate bone formation and bone marrow fat$550,866
R01 · FY2024 · AR · contact PI
The role of the osteocyte in responses to osteoporosis anabolic treatment in humans and mice$434,823
P50 · FY2024 · AR · contact PI
Mechanism of action of PTH: New signaling components that regulate bone formation and bone marrow fat$535,427
R01 · FY2023 · AR · contact PI
The role of the osteocyte in responses to osteoporosis anabolic treatment in humans and mice$416,894
P50 · FY2023 · AR · contact PI
Mechanism of action of PTH: New signaling components that regulate bone formation and bone marrow fat$562,224
R01 · FY2022 · AR · contact PI
Mechanism of action of PTH: New signaling components that regulate bone formation and bone marrow fat$550,866
R01 · FY2021 · AR · contact PI
The role of GGPS1 and CYP1A1 mutations in atypical femoral fracture$220,850
R21 · FY2021 · AR · contact PI
Mechanism of action of PTH: New signaling components that regulate bone formation and bone marrow fat$582,295
R01 · FY2020 · AR · contact PI
PTH resistance and marrow adipogenesis$552,366
R01 · FY2020 · DK · contact PI
The role of GGPS1 and CYP1A1 mutations in atypical femoral fracture$203,389
R21 · FY2020 · AR · contact PI
PTH resistance and marrow adipogenesis$552,366
R01 · FY2019 · DK · contact PI
PTH resistance and marrow adipogenesis$550,730
R01 · FY2018 · DK · contact PI
R-Spondin3 as a target for anabolic bone therapy$549,085
R01 · FY2018 · AR · contact PI
PTH resistance and marrow adipogenesis$576,593
R01 · FY2017 · DK · contact PI
R-Spondin3 as a target for anabolic bone therapy$549,085
R01 · FY2017 · AR · contact PI
Mechanisms and function of the microtubule podosome connection in osteoclasts$562,030
R01 · FY2016 · AR · contact PI
R-Spondin3 as a target for anabolic bone therapy$549,085
R01 · FY2016 · AR · contact PI
Mechanisms and function of the microtubule podosome connection in osteoclasts$562,030
R01 · FY2015 · AR · contact PI
R-Spondin3 as a target for anabolic bone therapy$549,085
R01 · FY2015 · AR · contact PI
AP1-dependent regulation of bone mass and energy expenditure in the hypothalamus$371,420
R01 · FY2015 · AG · contact PI
Role of Zfp521 in bone formation and anabolic responses$588,607
R01 · FY2014 · AR · contact PI
Mechanisms and function of the microtubule podosome connection in osteoclasts$550,789
R01 · FY2014 · AR · contact PI
R-Spondin3 as a target for anabolic bone therapy$549,085
R01 · FY2014 · AR · contact PI
AP1-dependent regulation of bone mass and energy expenditure in the hypothalamus$382,909
R01 · FY2014 · AG · contact PI
Role of Zfp521 in bone formation and anabolic responses$583,650
R01 · FY2013 · AR · contact PI
Mechanisms and function of the microtubule podosome connection in osteoclasts$533,928
R01 · FY2013 · AR · contact PI
AP1-dependent regulation of bone mass and energy expenditure in the hypothalamus$361,849
R01 · FY2013 · AG · contact PI
Calcitonin Regulation of Osteoclast Integrin Functions$344,336
R01 · FY2013 · AR · contact PI
Role of Zfp521 in bone formation and anabolic responses$614,368
R01 · FY2012 · AR · contact PI
Mechanisms and function of the microtubule podosome connection in osteoclasts$560,648
R01 · FY2012 · AR · contact PI
AP1-dependent regulation of bone mass and energy expenditure in the hypothalamus$382,909
R01 · FY2012 · AG · contact PI
Calcitonin Regulation of Osteoclast Integrin Functions$362,459
R01 · FY2012 · AR · contact PI
Regulation of Osteoblast Differentiation by Delta FosB$351,377
R01 · FY2012 · AR · contact PI
Role of Zfp521 in bone formation and anabolic responses$614,368
R01 · FY2011 · AR · contact PI
AP1-dependent regulation of bone mass and energy expenditure in the hypothalamus$382,909
R01 · FY2011 · AG · contact PI
Calcitonin Regulation of Osteoclast Integrin Functions$362,459
R01 · FY2011 · AR · contact PI
Regulation of Osteoblast Differentiation by Delta FosB$354,847
R01 · FY2011 · AR · contact PI
From Adhesion to Bone Resorption: The role of Dynamin in Osteoclasts$339,423
R01 · FY2011 · AR · contact PI
Role of Zfp521 in bone formation and anabolic responses$634,620
R01 · FY2010 · AR · contact PI
Calcitonin Regulation of Osteoclast Integrin Functions$377,561
R01 · FY2010 · AR · contact PI
Regulation of Osteoblast Differentiation by Delta FosB$369,171
R01 · FY2010 · AR · contact PI
From Adhesion to Bone Resorption: The role of Dynamin in Osteoclasts$353,566
R01 · FY2010 · AR · contact PI
Regulation of Osteoblast Differentiation by Delta FosB$1,063,933
R01 · FY2009 · AR · contact PI
Regulation of Osteoblast Differentiation by Delta FosB$372,900
R01 · FY2009 · AR · contact PI
From Adhesion to Bone Resorption: The role of Dynamin in Osteoclasts$356,698
R01 · FY2009 · AR · contact PI
Role of the C-src proto-oncogene in osteoclasts$346,505
R01 · FY2009 · AR · contact PI
Regulation of Osteoblast Differentiation by Delta FosB$371,800
R01 · FY2008 · AR · contact PI
From Adhesion to Bone Resorption: The role of Dynamin in Osteoclasts$356,083
R01 · FY2008 · AR · contact PI
Role of the C-src proto-oncogene in osteoclasts$345,483
R01 · FY2008 · AR · contact PI
Regulation of Osteoclastic Bone Resorption:Role of Cb1b$316,412
R01 · FY2008 · DE · contact PI
Regulation of Osteoclastic Bone Resorption:Role of Cb1b$66,894
R01 · FY2008 · DE · contact PI
Regulation of Osteoclastic Bone Resorption:Role of Cb1b$387,569
R01 · FY2007 · DE · contact PI
From Adhesion to Bone Resorption: The role of Dynamin in Osteoclasts$354,750
R01 · FY2007 · AR · contact PI
Role of the C-src proto-oncogene in osteoclasts$341,060
R01 · FY2007 · AR · contact PI
Role of the C-src proto-oncogene in osteoclasts$1
R01 · FY2007 · AR · contact PI
Regulation of Osteoclastic Bone Resorption:Role of Cb1b$399,144
R01 · FY2006 · DE · contact PI
OSTEOBLAST AND ADIPOCYTE DIFFERENTIATION BY FOSB$357,234
R01 · FY2006 · AR · contact PI
Role of the C-src proto-oncogene in osteoclasts$351,247
R01 · FY2006 · AR · contact PI
OSTEOBLAST AND ADIPOCYTE DIFFERENTIATION BY FOSB$17,658
R01 · FY2006 · AR · contact PI
OSTEOBLAST AND ADIPOCYTE DIFFERENTIATION BY FOSB$427,581
R01 · FY2005 · AR
Regulation of Osteoclastic Bone Resorption:Role of Cb1b$408,750
R01 · FY2005 · DE
Role of the C-src proto-oncogene in osteoclasts$359,700
R01 · FY2005 · AR
OSTEOBLAST AND ADIPOCYTE DIFFERENTIATION BY FOSB$456,629
R01 · FY2004 · AR
Regulation of Osteoclastic Bone Resorption:Role of Cb1b$408,750
R01 · FY2004 · DE
ROLE OF THE C-SRC PROTO-ONCOGENE IN OSTEOCLASTS$384,225
R01 · FY2004 · AR
OSTEOBLAST AND ADIPOCYTE DIFFERENTIATION BY FOSB$396,488
R01 · FY2003 · AR
ROLE OF THE C-SRC PROTO-ONCOGENE IN OSTEOCLASTS$384,225
R01 · FY2003 · AR
OSTEOBLAST AND ADIPOCYTE DIFFERENTIATION BY FOSB$39,763
R01 · FY2003 · AR
OSTEOBLAST AND ADIPOCYTE DIFFERENTIATION BY FOSB$389,096
R01 · FY2002 · AR
ROLE OF THE C-SRC PROTO-ONCOGENE IN OSTEOCLASTS$384,225
R01 · FY2002 · AR
REGULATION OF OSTEOCLASTIC BONE RESORPTION$337,836
R37 · FY2002 · DE
ROLE OF THE C-SRC PROTO-ONCOGENE IN OSTEOCLASTS$384,225
R01 · FY2001 · AR
REGULATION OF OSTEOCLASTIC BONE RESORPTION$329,614
R37 · FY2001 · DE
BC12 AND PTHRP REGULATED CHONDROCYTE MATURATION$317,167
R01 · FY2001 · AR
ROLE OF THE C-SRC PROTO-ONCOGENE IN OSTEOCLASTS$384,225
R01 · FY2000 · AR
REGULATION OF OSTEOCLASTIC BONE RESORPTION$330,270
R37 · FY2000 · DE
BC12 AND PTHRP REGULATED CHONDROCYTE MATURATION$307,931
R01 · FY2000 · AR